Viewing Study NCT03525392


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2026-01-12 @ 8:05 PM
Study NCT ID: NCT03525392
Status: TERMINATED
Last Update Posted: 2023-12-12
First Post: 2018-05-03
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Sponsor: Ipsen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-05-03
Start Date Type: ACTUAL
Primary Completion Date: 2020-04-03
Primary Completion Date Type: ACTUAL
Completion Date: 2021-04-28
Completion Date Type: ACTUAL
First Submit Date: 2018-05-03
First Submit QC Date: None
Study First Post Date: 2018-05-15
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-04-22
Results First Submit QC Date: None
Results First Post Date: 2023-12-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-02-23
Last Update Post Date: 2023-12-12
Last Update Post Date Type: ACTUAL